Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation.

Chemical Science
Hao LiuZijian Guo

Abstract

Amyloid-β (Aβ) oligomers, particularly low molecular weight (LMW) oligomers, rather than fibrils, contribute very significantly to the onset and progression of Alzheimer's Disease (AD). However, due to the inherent heterogeneity and metastability of oligomers, most of the conventional anti-oligomer therapies have indirectly modulated oligomers' toxicity through manipulating Aβ self-assembly to reduce oligomer levels, which are prone to suffering from the risk of regenerating toxic oligomers from the products of modulation. To circumvent this disadvantage, we demonstrate, for the first time, rational design of rigid pincer-like scaffold-based small molecules with blood-brain barrier permeability that specifically co-assemble with LMW Aβ oligomers through directly binding to the exposed hydrophobic regions of oligomers to form non-fibrillar, degradable, non-toxic co-aggregates. As a proof of concept, treatment with a europium complex (EC) in such a structural mode can rescue Aβ-mediated dysfunction in C. elegans models of AD in vivo. This small molecule-mediated oligomer co-assembly strategy offers an efficient approach for AD treatment.

References

Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·C D Link
Oct 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Woojin Kim, Michael H Hecht
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Jun 28, 2007·Biochemistry·Mihaela NeculaCharles G Glabe
May 31, 2008·Nature Structural & Molecular Biology·Dagmar E EhrnhoeferErich E Wanker
Sep 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Erica A FradingerGal Bitan
Oct 16, 2009·Nature·Richard J PerrinDavid M Holtzman
Jan 19, 2010·Nature Chemical Biology·Silvia CampioniFabrizio Chiti
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jan BieschkeErich E Wanker
Jun 1, 2010·The Journal of Biological Chemistry·Ali Reza A LadiwalaPeter M Tessier
Nov 26, 2010·The Journal of Biological Chemistry·Ali Reza A LadiwalaPeter M Tessier
Nov 22, 2011·Nature Chemical Biology·Jan BieschkeErich E Wanker
Jan 31, 2012·Nature Neuroscience·Iryna BenilovaBart De Strooper
Mar 13, 2012·Journal of Molecular Biology·Samuel I A CohenTuomas P J Knowles
May 2, 2012·The Journal of Biological Chemistry·Ali Reza A LadiwalaPeter M Tessier
Jul 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Benedetta ManniniFabrizio Chiti
Sep 12, 2012·Autophagy·Daniel J KlionskyBrian Zuckerbraun
Sep 22, 2012·Journal of the American Chemical Society·Evan A WeitzValerie C Pierre
Mar 20, 2013·ACS Chemical Biology·Masha G SavelieffMi Hee Lim
May 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Samuel I A CohenTuomas P J Knowles
Aug 8, 2013·Nature Medicine·Ralph A Nixon
Feb 18, 2014·Journal of the American Chemical Society·Nikolai LorenzenDaniel Erik Otzen
Mar 26, 2014·Journal of the American Chemical Society·Yang SongJeffrey S Moore
Jun 19, 2014·Proceedings of the National Academy of Sciences of the United States of America·Georg MeislTuomas P J Knowles
Sep 30, 2014·Chembiochem : a European Journal of Chemical Biology·Tadamasa AraiMotomu Kanai
Apr 16, 2015·Chemical Communications : Chem Comm·Xiaohui WangCheng Yao
Jun 5, 2015·Journal of the American Chemical Society·Lijuan ZhuJeffrey S Moore
Jul 22, 2015·Nature Reviews. Neurology·Jenna M Tarasoff-ConwayMony J de Leon
Jul 29, 2015·Journal of the American Chemical Society·Chai Lean TeohYoung-Tae Chang
Nov 5, 2015·Journal of the American Chemical Society·Olga SzczepankiewiczSara Linse
Dec 22, 2015·Chemical Communications : Chem Comm·Tao YangXiaoyong Wang
Jan 8, 2016·Nature Protocols·Georg MeislTuomas P J Knowles
Mar 12, 2016·Journal of the American Chemical Society·Adam G KreutzerJames S Nowick
May 7, 2016·ACS Applied Materials & Interfaces·Sayan Roy ChowdhuryParameswar Krishnan Iyer
Oct 24, 2017·Journal of the American Chemical Society·Sunil KumarAndrew D Hamilton

❮ Previous
Next ❯

Citations

Jul 7, 2021·Current Opinion in Chemical Biology·Tuan D SamdinJames S Nowick

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
Dot blot
electrophoresis
transmission electron microscopy
dynamic light scattering
transgenic

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.